Pathophysiologic cascades in ischemic stroke - PubMed (original) (raw)
Review
Pathophysiologic cascades in ischemic stroke
Changhong Xing et al. Int J Stroke. 2012 Jul.
Abstract
Many advances have been achieved in terms of understanding the molecular and cellular mechanisms of ischemic stroke. But thus far, clinically effective neuroprotectants remain elusive. In this minireview, we summarize the basics of ischemic cascades after stroke, covering neuronal death mechanisms, white matter pathophysiology, and inflammation with an emphasis on microglia. Translating promising mechanistic knowledge into clinically meaningful stroke drugs is very challenging. An integrative approach that encompasses the multimodal and multicell signaling phenomenon of stroke will be required to move forward.
© 2012 The Authors. International Journal of Stroke © 2012 World Stroke Organization.
Conflict of interest statement
Conflict of interest: None declared.
Figures
Fig. 1
Schematic showing the nonlinear and highly integrative aspects of stroke pathophysiology. Mechanisms can be manifested at multiple levels of phenomenology, ranging from molecular and cellular biology to whole animal physiology and pharmacology to individual human subjects and population responses. The influence of genetics and risk factors adds to this complexity. And ultimately, these multifactorial processes connect into spatial and temporal gradients of tissue injury and repair. Altogether, this matrix represents a series of hurdles that must be considered before translation can take place. Finding clinically effective therapeutics for stroke prevention, treatment, and recovery is challenging. Multitarget integrative solutions may be required.
Similar articles
- Intranasal Delivery of Apelin-13 Is Neuroprotective and Promotes Angiogenesis After Ischemic Stroke in Mice.
Chen D, Lee J, Gu X, Wei L, Yu SP. Chen D, et al. ASN Neuro. 2015 Sep 21;7(5):1759091415605114. doi: 10.1177/1759091415605114. Print 2015 Sep-Oct. ASN Neuro. 2015. PMID: 26391329 Free PMC article. - Apoptosis and Acute Brain Ischemia in Ischemic Stroke.
Radak D, Katsiki N, Resanovic I, Jovanovic A, Sudar-Milovanovic E, Zafirovic S, Mousad SA, Isenovic ER. Radak D, et al. Curr Vasc Pharmacol. 2017;15(2):115-122. doi: 10.2174/1570161115666161104095522. Curr Vasc Pharmacol. 2017. PMID: 27823556 Review. - Microthrombus-Targeting Micelles for Neurovascular Remodeling and Enhanced Microcirculatory Perfusion in Acute Ischemic Stroke.
Lu Y, Li C, Chen Q, Liu P, Guo Q, Zhang Y, Chen X, Zhang Y, Zhou W, Liang D, Zhang Y, Sun T, Lu W, Jiang C. Lu Y, et al. Adv Mater. 2019 May;31(21):e1808361. doi: 10.1002/adma.201808361. Epub 2019 Apr 8. Adv Mater. 2019. PMID: 30957932 - Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke.
Shabanzadeh AP, Shuaib A, Wang CX. Shabanzadeh AP, et al. Brain Res. 2005 Apr 25;1042(1):1-5. doi: 10.1016/j.brainres.2005.01.105. Brain Res. 2005. PMID: 15823246 - Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia.
Leker RR, Neufeld MY. Leker RR, et al. Brain Res Brain Res Rev. 2003 Jun;42(3):187-203. doi: 10.1016/s0165-0173(03)00170-x. Brain Res Brain Res Rev. 2003. PMID: 12791439 Review.
Cited by
- Methodological Approaches to Experimental Evaluation of Neuroprotective Action of Potential Drugs.
Belenichev I, Bukhtiyarova N, Ryzhenko V, Makyeyeva L, Morozova O, Oksenych V, Kamyshnyi O. Belenichev I, et al. Int J Mol Sci. 2024 Sep 28;25(19):10475. doi: 10.3390/ijms251910475. Int J Mol Sci. 2024. PMID: 39408802 Free PMC article. Review. - Role of RNA polymerase III transcription and regulation in ischaemic stroke.
Tsang CK, Zheng XFS. Tsang CK, et al. RNA Biol. 2024 Jan;21(1):1-10. doi: 10.1080/15476286.2024.2409554. Epub 2024 Oct 3. RNA Biol. 2024. PMID: 39363536 Free PMC article. Review. - An Organic Fraction of Oenothera rosea L'Her Ex. Aiton Prevents Neuroinflammation in a Rat Ischemic Model.
Costet-Mejía A, Trejo-Tapia G, Baca-Ibarra II, Rodríguez-Hernández AA, García-Hernández J, Camacho-Díaz BH, Zamilpa A. Costet-Mejía A, et al. Pharmaceuticals (Basel). 2024 Sep 9;17(9):1184. doi: 10.3390/ph17091184. Pharmaceuticals (Basel). 2024. PMID: 39338346 Free PMC article. - Role of Microglia in Stroke.
Cipriani R, Domerq M, Martín A, Matute C. Cipriani R, et al. Adv Neurobiol. 2024;37:405-422. doi: 10.1007/978-3-031-55529-9_23. Adv Neurobiol. 2024. PMID: 39207705 Review. - A comprehensive review on the neuroprotective potential of resveratrol in ischemic stroke.
Owjfard M, Rahimian Z, Karimi F, Borhani-Haghighi A, Mallahzadeh A. Owjfard M, et al. Heliyon. 2024 Jul 5;10(14):e34121. doi: 10.1016/j.heliyon.2024.e34121. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39082038 Free PMC article. Review.
References
- WHO. Projections of mortality and burden of disease, 2002–2030. Available at http://www.who.int/healthinfo/global_burden_disease/projections2002/en/i.... - PMC - PubMed
- Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 2003;4:399–415. - PubMed
- Candelario-Jalil E. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. Curr Opin Investig Drugs. 2009;10:644–54. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical